Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Non-cash Items (2018 - 2025)

Historic Non-cash Items for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q3 2025 value amounting to $3.2 million.

  • Whitehawk Therapeutics' Non-cash Items changed N/A to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2021, which is N/A changed from last year.
  • Whitehawk Therapeutics' Non-cash Items amounted to $3.2 million in Q3 2025.
  • In the past 5 years, Whitehawk Therapeutics' Non-cash Items ranged from a high of $10.0 million in Q4 2021 and a low of $459000.0 during Q2 2025
  • Moreover, its 3-year median value for Non-cash Items was $2.2 million (2021), whereas its average is $3.3 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first tumbled by 8120.02% in 2021, then soared by 39990.99% in 2022.
  • Whitehawk Therapeutics' Non-cash Items (Quarter) stood at $10.0 million in 2021, then plummeted by 43.72% to $5.6 million in 2022, then plummeted by 42.35% to $3.2 million in 2025.
  • Its Non-cash Items stands at $3.2 million for Q3 2025, versus $459000.0 for Q2 2025 and $5.6 million for Q1 2022.